MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, TBPH has $415,460K in assets. $174,773K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
948.21%
Cash Ratio
467.22%
Assets Breakdown
    • Cash and cash equivalents
    • Short-term marketable securities
    • Operating lease assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Unrecognized tax benefits
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
174,773 281,927
Short-term marketable securities
154,907 56,877
Receivables from collaborative arrangements
18,267 21,919
Other prepaid and current assets
6,750 5,571
Total current assets
354,697 366,294
Long-term marketable securities
3,029 -
Property and equipment, net
6,257 6,641
Operating lease assets
25,450 26,493
Restricted cash
836 836
Other assets
25,191 25,771
Total assets
415,460 426,035
Accounts payable
2,213 1,675
Accrued personnel-related expenses
10,330 7,259
Accrued clinical and development expenses
5,842 3,783
Accrued general and administrative expenses
2,699 2,459
Operating lease liabilities
10,914 10,896
Income tax payable
4,074 26,696
Other accrued liabilities
1,335 1,865
Total current liabilities
37,407 54,633
Long-term operating lease liabilities
33,681 35,561
Future royalty payment contingency
32,213 31,640
Unrecognized tax benefits
79,165 77,805
Other long-term liabilities
313 1,548
Ordinary shares, 0.00001 par value per share 200,000 shares authorized 50,672 and 49,471 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
1 1
Additional paid-in capital
1,153,299 1,149,123
Accumulated other comprehensive income
32 -10
Accumulated deficit
-920,651 -924,266
Total shareholders' equity
232,681 224,848
Total liabilities and shareholders' equity
415,460 426,035
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other prepaid andcurrent assets$6,750K Receivables fromcollaborative arrangements$18,267K Short-term marketablesecurities$154,907K Cash and cashequivalents$174,773K Other assets$25,191K Restricted cash$836K Operating lease assets$25,450K Property and equipment,net$6,257K Long-term marketablesecurities$3,029K Total current assets$354,697K Total assets$415,460K Total liabilities andshareholders' equity$415,460K Total shareholders'equity$232,681K Other long-termliabilities$313K Unrecognized tax benefits$79,165K Future royalty paymentcontingency$32,213K Long-term operating leaseliabilities$33,681K Total currentliabilities$37,407K Accumulated deficit-$920,651K Accumulated othercomprehensive income$32K Additional paid-in capital$1,153,299K Other accruedliabilities$1,335K Income tax payable$4,074K Operating leaseliabilities$10,914K Accrued general andadministrative expenses$2,699K Accrued clinical anddevelopment expenses$5,842K Accruedpersonnel-related expenses$10,330K Accounts payable$2,213K Ordinary shares, 0.00001par value per share...$1K

Theravance Biopharma, Inc. (TBPH)

Theravance Biopharma, Inc. (TBPH)